Phase III News
Most Popular Phase III Story
The Top 10 Phase III Failures of 2010
By Phase III, researchers are supposed to have a pretty good handle on just how promising an experimental therapy can be. There's proof-of-concept data in the can and some clear indications of just Read more...
Latest Headlines
- January 6, 2012
- October 6, 2011
- September 30, 2011
- September 16, 2011
- August 28, 2011
- August 26, 2011
- August 24, 2011
- August 2, 2011
- July 18, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
